全文获取类型
收费全文 | 1188篇 |
免费 | 59篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 53篇 |
儿科学 | 57篇 |
妇产科学 | 17篇 |
基础医学 | 120篇 |
口腔科学 | 17篇 |
临床医学 | 90篇 |
内科学 | 250篇 |
皮肤病学 | 11篇 |
神经病学 | 39篇 |
特种医学 | 259篇 |
外科学 | 89篇 |
综合类 | 25篇 |
预防医学 | 47篇 |
眼科学 | 16篇 |
药学 | 48篇 |
1篇 | |
中国医学 | 8篇 |
肿瘤学 | 103篇 |
出版年
2021年 | 6篇 |
2019年 | 11篇 |
2018年 | 9篇 |
2017年 | 10篇 |
2016年 | 16篇 |
2015年 | 19篇 |
2014年 | 12篇 |
2013年 | 21篇 |
2012年 | 17篇 |
2011年 | 40篇 |
2010年 | 31篇 |
2009年 | 31篇 |
2008年 | 24篇 |
2007年 | 21篇 |
2006年 | 33篇 |
2005年 | 32篇 |
2004年 | 18篇 |
2003年 | 17篇 |
2002年 | 24篇 |
2001年 | 25篇 |
2000年 | 30篇 |
1999年 | 31篇 |
1998年 | 47篇 |
1997年 | 40篇 |
1996年 | 41篇 |
1995年 | 54篇 |
1994年 | 39篇 |
1993年 | 39篇 |
1992年 | 23篇 |
1991年 | 15篇 |
1990年 | 34篇 |
1989年 | 49篇 |
1988年 | 28篇 |
1987年 | 42篇 |
1986年 | 46篇 |
1985年 | 31篇 |
1984年 | 22篇 |
1983年 | 18篇 |
1982年 | 19篇 |
1981年 | 21篇 |
1980年 | 23篇 |
1979年 | 20篇 |
1978年 | 21篇 |
1977年 | 17篇 |
1976年 | 15篇 |
1975年 | 14篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1971年 | 5篇 |
1957年 | 6篇 |
排序方式: 共有1250条查询结果,搜索用时 46 毫秒
1.
C. Lebrun S. Olschwang S. Jeannin F. Vandenbos H. Sobol M. Frenay 《European journal of neurology》2007,14(4):470-472
Turcot syndrome is clinically characterized by the occurrence of primary brain tumor and colorectal tumor and has, in previous reports, been shown associated with germline mutations in the genes APC , MLH1 , MHS6 , and PMS2 . To date, only few families have been documented by molecular analysis. We report two new families with Turcot syndrome to illustrate and review its characteristics and facilitate diagnosis. Molecular analysis revealed two germline mutations, one in the MLH1 gene and one in MSH2 . The latter has never been describe in the literature. Personal and familial relevant anamnestic data from patients with glioma might aid in the diagnosis of genetic disorders. The subsequent molecular characterization may contribute to the appropriate care of affected patients and asymptomatic gene carriers. 相似文献
2.
3.
4.
RAFAEL BEYAR M.D. D.Sc. ARIEL ROGUIN M.D. JAAP HAMBURGER M.D. RE SAAIMAN M.D. ANTONIO L. BARTORELLI M.D. CARLO DiMARIO M.D. ANTONIO COLOMBO M.D. CHRISTIAN W. HAMM M.D. CHRISTOPHER J. WHITE M.D. J. MARCO M.D. PATRICK W. SERRUYS M.D. Ph.D. 《Journal of interventional cardiology》1997,10(4):277-286
The beStent is a new stainless steel, balloon-expandable mesh stent which has a unique serpentine design. Rotation of the unique low stress junctions upon expansion leads to orthogonal locking of the wires, maximizing radial strength and assuring zero shortening. The stent has delineating gold markers which assure precise positioning. We aim to present the initial acute results in a pilot registry for stent evaluation. Two hundred eighty-four stents were used in a total of 217 patients (age 57.9 ± 3.10 years; 178 males; 39 females) in seven centers, for variable indications. Stents of 15-, 25-, and 35-mm length were used. The arteries treated were the left anterior descending (n = 112, 42%), circumflex (n = 54, 20.2%), right coronary (n = 95, 35.5%), left main (n = 1, 0.4%), and vein graft (n = 5, 1.9%). Lesion types were: A in 42 patients (16.5%); B1 in 53 patients (20.7%); B2 in 81 patients (31.8%); and C in 79 patients (31%). One hundred fifty-nine patients required one stent, 40 patients required two stents, and 18 patients required three or more stents. Anticoagulation protocol included procedural heparin with aspirin with/without ticlopidine. Smooth angiographie results were obtained in all cases with no plaque herniation. Acute angiographic success was obtained in 97% of the patients, and acute clinical success in 95% of the patients. Complications within 30 days were: 3 deaths (1.4%) (2 noncardiac); 2 (0.9%) myocardial infarctions; and 2 (0.9%) stent thromboses. Therefore, the beStent is useful in treatment of complex lesions of variable length and complexity, providing excellent acute results with a low complication rate, in spite of unfavorable basic clinical and angiographie characteristics. 相似文献
5.
Evaluation of a new magnetic resonance imaging method for quantitating adipose tissue areas 总被引:3,自引:0,他引:3
W Sobol S Rossner B Hinson E Hiltbrandt N Karstaedt P Santago N Wolfman A Hagaman J R Crouse 《International journal of obesity (2005)》1991,15(9):589-599
We have developed a new magnetic resonance imaging (MRI) protocol to quantitate intraabdominal and subcutaneous fat and have validated it by comparing measurements of fat areas by MRI with those obtained by computed tomography (CT) in 11 asymptomatic volunteers who all had a single CT and MRI image taken at the level of the umbilicus. The new MRI protocol was based on a water-fat separation method by which the slice selection routines excite water and fat protons in different positions along the slice select direction. This method performed more reliably than earlier methods based on phase differences between water and fat signals. Fat areas measured by MRI exceeded those measured by CT by 8-22 percent, and fat areas and ratios obtained by MRI correlated well with CT (r = 0.98 for areas and, for ratios, r = 0.81). The ratio of intraabdominal/subcutaneous fat measured by MRI in seven males was significantly greater than that in four females. We also compared the new method with a previously published inversion recovery (IR) method in seven additional volunteers. Agreement between the two methods was excellent, and the major differences were technical: the IR protocol produced images that may require custom image processing programs when obtained on some scanners. Comparability of the two methods provides further reassurance of the validity of both. MRI presents an attractive opportunity for directly measuring intraabdominal fat in order to correlate this with metabolic parameters and to visualize changes during weight loss. 相似文献
6.
7.
Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: preliminary clinical results 总被引:3,自引:0,他引:3
Mattrey RF; Strich G; Shelton RE; Gosink BB; Leopold GR; Lee T; Forsythe J 《Radiology》1987,163(2):339-343
In animals, perfluorochemicals (PFCs) are effective ultrasound (US) contrast agents that produce hepatic, splenic, and tumor enhancement. The use of Fluosol-DA 20%, an emulsion of perfluorodecalin and perfluorotripropylamine, was studied in nine non-critically ill patients with cancer who had liver lesions. US studies without Fluosol were compared with studies obtained 24, 48, and 72 hours after Fluosol infusion. Vital signs and extensive laboratory analyses are performed before and after Fluosol infusion. Liver metastases from colonic, pancreatic, and gastric carcinoma exhibited rim or diffuse enhancement after a Fluosol dose of 1.6 g/kg or greater. Fluosol produced echogenic enhancement of the liver and spleen relative to kidney at a dose of 2.4 g/kg, allowing the detection of nonenhancing lesions. In addition, Fluosol at a dose of 1.6 g/kg or greater allowed detection of lesions not seen before contrast medium was administered in three of the seven patients studied. There was a mild increase in the level of serum glutamic oxaloacetic transaminase in two patients, one given 2.4 and the other 3.2 g/kg of Fluosol. Mild and transient allergic reactions without change in vital signs were experienced by two patients. 相似文献
8.
9.
Early facial reanimation following radical parotid and temporal bone tumor resections 总被引:1,自引:0,他引:1
A retrospective study of 35 patients who underwent early facial reanimation following extirpative parotid and temporal bone surgery requiring facial nerve sacrifice was performed. Regional facial reanimation performed immediately or within several days included 16 patients who underwent temporalis muscle transposition and 27 who underwent gold weight or eyespring lid reanimation with lower lid tightening. Simultaneous nerve grafts or nerve crossover procedures were performed in 22 patients. The authors' favored approaches to facial reanimation are discussed, with an emphasis on the value of early reanimation using properly selected techniques. 相似文献
10.
Coralline hydroxyapatite bone graft substitutes: preliminary report of radiographic evaluation 总被引:1,自引:0,他引:1
A new bone graft substitute made by conversion of the calcium carbonate exoskeleton of reef-building sea coral into hydroxyapatite has recently become clinically available. The normal radiographic appearance of two forms of this material is described. In the immediate postoperative period, the exoskeletal architecture of these implants is readily appreciated. With graft incorporation over the ensuing months, their intrinsic structure is gradually lost in association with poor marginal definition. Evolving radiographic findings reflect the biocompatible nature of these implants, which provides the potential for ingrowth of native bone with preservation of the coralline scaffold, resulting in enhanced biomechanical properties. 相似文献